<!DOCTYPE html SYSTEM "about:legacy-compat">
<html lang="en-US" class="no-js">
  <head>
    <meta charset="utf-8"/>
    <title>Subtitle 13 DRUGS | Library of Maryland Regulations</title>
    <link rel="shortcut icon" href="/us/md/exec/_document/v2/images/favicons/favicon.ico"/>
    <!--Meta-->
    <meta http-equiv="X-UA-Compatible" content="IE=EDGE"/>
    <meta name="viewport" content="width=device-width, initial-scale=1"/>
    <meta name="format-detection" content="telephone=no"/>
    <meta name="HandheldFriendly" content="true"/>
    <meta itemprop="full-html" content="/us/md/exec/comar/10.13/index.full.html" data-document="href"/>
    <meta itemprop="toc-json" content="/us/md/exec/comar/10.13/index.json" data-document="href"/>
    <meta itemprop="parent-doc-url" content="/us/md/exec/comar" data-document="href"/>
    <meta itemprop="order" content="|10|13|"/>
    <meta itemprop="doc-type" content="container" data-document=""/>
    <meta itemprop="ref-doc" content="Code of Maryland Regulations" data-document=""/>
    <meta itemprop="ref-path" content="10|13" data-document=""/>
    <!--OpenGraph-->
    <meta property="og:url" content="/us/md/exec/comar/10.13"/>
    <meta property="og:type" content="article"/>
    <meta property="og:title" content="Subtitle 13 DRUGS | Library of Maryland Regulations"/>
    <meta property="og:image" content="/us/md/exec/_document/v2/images/og/og_image.png"/>
    <!--Progressive Web App-->
    <link rel="manifest" href="/manifest.json"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="apple-mobile-web-app-status-bar-style" content="#0078EF"/>
    <meta name="apple-mobile-web-app-title" content="Library of Maryland Regulations"/>
    <meta name="theme-color" content="#0078EF"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="mobile-web-app-capable" content="yes"/>
    <!--PWA icons-->
    <link rel="apple-touch-icon" sizes="180x180" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="60x60" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-60x60-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="76x76" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-76x76-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="152x152" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-152x152-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="180x180" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-180x180-precomposed.png"/>
    <link rel="mask-icon" href="/us/md/exec/_document/v2/images/favicons/safari-pinned-tab.svg" color="#0078EF"/>
    <link rel="icon" type="image/png" sizes="16x16" href="/us/md/exec/_document/v2/images/favicons/favicon-16x16.png"/>
    <link rel="icon" type="image/png" sizes="32x32" href="/us/md/exec/_document/v2/images/favicons/favicon-32x32.png"/>
    <link rel="icon" type="image/png" sizes="48x48" href="/us/md/exec/_document/v2/images/favicons/favicon-48x48.png"/>
    <!--Fonts-->
    <link href="/us/md/exec/_document/v2/biticons/biticons.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/public-sans/public-sans.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/merriweather/merriweather.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/roboto-mono/roboto-mono.css" type="text/css" rel="stylesheet" data-document=""/>
    <!--Document CSS-->
    <link href="/us/md/exec/_document/v2/styles/responsive.min.css" type="text/css" rel="stylesheet" media="screen" data-document=""/>
    <link href="/us/md/exec/_document/v2/styles/main.min.css" type="text/css" rel="stylesheet" media="screen" data-document=""/>
    <link href="/us/md/exec/_document/v2/styles/print.min.css" type="text/css" rel="stylesheet" media="print" data-document=""/>
    <link href="/_reader/styles/main.min.css" type="text/css" rel="stylesheet"/>
    <script src="/_reader/js/main.js" data-document=""> </script>
    <!--Links to resources that need to be prefetched-->
    <link rel="prefetch" href="/us/md/exec/comar/10.13/index.full.html" as="fetch"/>
    <link rel="prefetch" href="/index.json" as="fetch"/>
    <link rel="prefetch" href="/us/md/exec/comar/10.13/index.json" as="fetch"/>
  </head>
  <body>
    <div role="region" id="announcer" aria-live="polite" class="sr-only" aria-atomic="true" aria-label="Live messages">
      <p id="message"> </p>
    </div>
    <nav class="visually-hidden">
      <a href="#area__content" class="skip-link">Skip to main content</a>
    </nav>
    <div id="grid" class="ns__document__maryland-dsd">
      <header id="section__header" class="ns__document__maryland-dsd">
        <div id="section__header__inner" class="ns__document__maryland-dsd">
          <div id="area__logo" class="ns__document__maryland-dsd">
            <a href="/" class="logo" aria-label="Logo - Return to library home page">
              <img src="/us/md/exec/_document/v2/images/logo/logo.png" srcset="/us/md/exec/_document/v2/images/logo/logo.png 1x, /us/md/exec/_document/v2/images/logo/logo@2x.png 2x, /us/md/exec/_document/v2/images/logo/logo@3x.png 3x" alt="Library of Maryland Regulations logo"/>
            </a>
          </div>
          <div id="area__main_title" class="ns__document__maryland-dsd">
            <div class="h__library-logotype"><span class="line1">Library of</span> <span class="line2">Maryland Regulations</span></div>
          </div>
        </div>
      </header>
      <div id="section__content" class="ns__document__maryland-dsd">
        <div id="section__content__inner" class="ns__document__maryland-dsd">
          <section id="area__breadcrumbs" class="ns__document__maryland-dsd" role="region" aria-label="Breadcrumbs">
            <input type="checkbox" id="menu-trigger" class="menu-trigger" aria-label="Mobile menu toggler"/>
            <label for="menu-trigger">
              <span class="visually-hidden">Toggle mobile menu</span>
            </label>
            <nav role="navigation" aria-label="Breadcrumb navigation">
              <div class="h__ui">Navigation</div>
              <ul class="ancestors">
                <li data-search-path="library" data-search-heading="All Documents" class="no-indent">
                  <a href="/" title="Library of Maryland Regulations">Library of Maryland Regulations</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations" data-search-heading="" data-search-default="true" class="li__book-open">
                  <a href="/us/md/exec/comar" title="Code of Maryland Regulations">Code of Maryland Regulations</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10" data-search-heading="">
                  <a href="/us/md/exec/comar/10" title="Title 10 MARYLAND DEPARTMENT OF HEALTH">Title 10 MARYLAND DEPARTMENT OF HEALTH</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10|13" data-search-heading="">
                  <span title="Subtitle 13 DRUGS">Subtitle 13 DRUGS</span>
                </li>
              </ul>
            </nav>
          </section>
          <main id="area__content" class="ns__document__maryland-dsd">
            <div class="h__document-title">Code of Maryland Regulations</div>
            <article class="content" role="document" data-ref-path="10|13">
              <div class="tuf-authenticate">
                <h1 class="h__toc" id="/us/md/exec/comar/10.13">Subtitle 13 DRUGS</h1>
                <h2 id="/us/md/exec/comar/10.13.01" data-order="|10|13|01|" data-ref-path="10|13|01" class="h__chapter">Chapter 01 Dispensing of Prescription Drugs by a Licensee</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: September 19, 1935</p>
                  <p>Chapter, Permits for Sale of Poisons by General Merchants, repealed effective July 10, 1989  (16:13 Md. R. 1421)</p>
                  <p>Chapter, Dispensing of Prescription Drugs by a Licensee, adopted effective May 11, 1992 (19:9 Md. R. 879)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.13.01.03#A" title="">Regulation .03A</a> amended effective March 6, 2000 (27:4 Md. R. 453)</p>
                  <p>——————</p>
                  <p>Chapter revised effective June 22, 2015 (42:12 Md. R. 762)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.13.01.02#B" title="">Regulation .02B</a> amended effective March 26, 2018 (45:6 Md. R. 320)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.13.01.03#A" title="">Regulation .03A</a> amended effective March 26, 2018 (45:6 Md. R. 320)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.13.01.04#D" title="">Regulation .04D</a>, N amended effective March 26, 2018 (45:6 Md. R. 320)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.13.01.04#S" title="">Regulation .04S</a> adopted effective March 26, 2018 (45:6 Md. R. 320)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.13.01.05" title=".05 Inspection Requirements.">Regulation .05</a> amended effective March 26, 2018 (45:6 Md. R. 320)</p>
                  <h3>Authority</h3>
                  <p>Health Occupations Article, §§<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-102" title="">12-102</a> and <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-102" title="">12-102</a>.1, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.13.01.01" data-order="|10|13|01|.01|" data-ref-path="10|13|01|.01" class="h__section">.01 Scope.</h3>
                <p>This chapter defines the parameters under which a licensee may dispense prescription drugs in accordance with <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-102" title="">Health Occupations Article, §12-102, Annotated Code of Maryland</a>.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.13.01.02" data-order="|10|13|01|.02|" data-ref-path="10|13|01|.02" class="h__section">.02 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.01.02#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.01.02#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.01.02#B(1)">(1)</span> "Board" means the Board of Dental Examiners, the Board of Physicians, or the Board of Podiatric Medical Examiners.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.01.02#B(2)">(2)</span> Final Check.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.01.02#B(2)(a)">(a)</span> “Final check” means the verification of the accuracy and completeness of a filled prescription order by the permit holder before the drug is dispensed to the patient.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.01.02#B(2)(b)">(b)</span> “Final check” includes the assumption of responsibility for the filled prescription, including verifying the:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.13.01.02#B(2)(b)(i)">(i)</span> Appropriateness of the dose;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.13.01.02#B(2)(b)(ii)">(ii)</span> Accurate expiration date;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.13.01.02#B(2)(b)(iii)">(iii)</span> Accuracy of the drug dispensed;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.13.01.02#B(2)(b)(iv)">(iv)</span> Strength of the drug dispensed;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.13.01.02#B(2)(b)(v)">(v)</span> Labeling that complies with <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-505" title="">Health Occupations Article, §12-505, Annotated Code of Maryland</a>; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.13.01.02#B(2)(b)(vi)">(vi)</span> Appropriateness of the container in which the drug is dispensed, including child-proof containers where applicable.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.01.02#B(3)">(3)</span> "Licensee" means the dentist, physician, or podiatrist who is licensed by the appropriate Board to practice in Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.01.02#B(4)">(4)</span> “Personally preparing and dispensing” means the licensed dentist, physician, or podiatrist:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.01.02#B(4)(a)">(a)</span> Is physically present on the premises where the prescription is filled; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.01.02#B(4)(b)">(b)</span> Performs a final check of the prescription before it is dispensed to the patient.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.01.02#B(5)">(5)</span> "Public interest" means the dispensing of prescription drugs by a licensee to a patient when a pharmacy is not conveniently available to the patient.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.13.01.03" data-order="|10|13|01|.03|" data-ref-path="10|13|01|.03" class="h__section">.03 Application for Dispensing Permit.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.01.03#A">A.</span> The licensee shall complete an application on a form approved by the appropriate Board and pay a fee in accordance with the fee schedule for:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.01.03#A(1)">(1)</span> Physicians at <a class="internal-link no-wrap" href="/us/md/exec/comar/10.32.01.12" title=".12 Fees.">COMAR 10.32.01.12</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.01.03#A(2)">(2)</span> Podiatrists at <a class="internal-link no-wrap" href="/us/md/exec/comar/10.40.03" title="Chapter 03 Collection of Fees">COMAR 10.40.03</a>; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.01.03#A(3)">(3)</span> Dentists at <a class="internal-link no-wrap" href="/us/md/exec/comar/10.44.20" title="Chapter 20 Fees">COMAR 10.44.20</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.01.03#B">B.</span> The application shall require the following information to indicate that the applicant is personally preparing and dispensing prescription drugs in the public interest:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.01.03#B(1)">(1)</span> The name, address, and license number of the applicant;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.01.03#B(2)">(2)</span> An attestation by the applicant that the applicant shall comply with the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.01.03#B(2)(a)">(a)</span> Dispensing requirements set forth in <a class="internal-link " href="/us/md/exec/comar/10.13.01.04" title=".04 Dispensing Requirements.">Regulation .04 of this chapter</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.01.03#B(2)(b)">(b)</span> Inspection requirements set forth in <a class="internal-link " href="/us/md/exec/comar/10.13.01.05" title=".05 Inspection Requirements.">Regulation .05 of this chapter</a>; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.01.03#B(2)(c)">(c)</span> Statutes and regulations governing dispensing of prescription drugs set forth in <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Title 12, Annotated Code of Maryland</a>, <a class="internal-link no-wrap" href="/us/md/exec/comar/10.19.03" title="Chapter 03 Controlled Dangerous Substances">COMAR 10.19.03</a>, and <a class="internal-link no-wrap" href="/us/md/exec/comar/10.34" title="Subtitle 34 BOARD OF PHARMACY">COMAR 10.34</a>; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.01.03#B(3)">(3)</span> The address of each practice location where the applicant dispenses prescription drugs.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.01.03#C">C.</span> Each permit issued to a licensee expires 5 years after its date of issuance and is renewable upon timely submission of a renewal application in accordance with the requirements set forth in this regulation. The fee schedule set forth in <a class="internal-link " href="/us/md/exec/comar/10.13.01.03#A" title="">§A of this regulation</a> applies to all renewal applications.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.01.03#D">D.</span> Continuing Education Requirement.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.01.03#D(1)">(1)</span> A permit holder shall complete 10 continuing education credits over a 5-year period relating to the preparing and dispensing of prescription drugs as a condition of permit renewal.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.01.03#D(2)">(2)</span> The continuing education credit requirement shall be implemented in accordance with Ch. 267, §2, Acts of 2012.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.01.03#E">E.</span> A permit issued to a licensee shall be nontransferable.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.13.01.04" data-order="|10|13|01|.04|" data-ref-path="10|13|01|.04" class="h__section">.04 Dispensing Requirements.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.01.04#A">A.</span> A licensee shall submit an application to the appropriate Board on the form that the Board requires.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.01.04#B">B.</span> A licensee may not dispense prescription drugs until a written permit is received from the appropriate Board, except that a written permit is not required in order to dispense starter dosages or samples provided without charge.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.01.04#C">C.</span> A licensee shall personally prepare and dispense prescription drugs.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.01.04#D">D.</span> Except as provided in <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-102" title="">Health Occupations Article, §12-102(c)(2)(iii), Annotated Code of Maryland</a>, and <a class="internal-link " href="/us/md/exec/comar/10.13.01.04#S" title="">§S of this regulation</a>, a licensee shall dispense prescription drugs only to the patients of the licensee.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.01.04#E">E.</span> A licensee shall comply with the labeling requirements set forth in <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-505" title="">Health Occupations Article, §12-505, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.01.04#F">F.</span> A licensee shall comply with the child resistant packaging requirements set forth in Health-General Article, Title 22, Subtitle 3, Annotated Code of Maryland.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.01.04#G">G.</span> A licensee shall comply with drug recalls.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.01.04#H">H.</span> A licensee shall record the dispensing of the prescription drug on the patient's chart.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.01.04#I">I.</span> A licensee may not have a substantial financial interest in a pharmacy.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.01.04#J">J.</span> A licensee shall, except for starter dosages or samples provided without charge, provide the patient with a written prescription.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.01.04#K">K.</span> A licensee shall maintain for at least 5 years:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.01.04#K(1)">(1)</span> A separate file for Schedule II prescriptions; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.01.04#K(2)">(2)</span> Another file for other prescriptions.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.01.04#L">L.</span> A licensee shall maintain biennial inventories of all stocks of controlled substances.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.01.04#M">M.</span> A licensee shall dispense prescription drugs to a patient only when the patient determines that a pharmacy is not conveniently available to the patient.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.01.04#N">N.</span> In each patient’s chart for each patient to whom prescription drugs are dispensed or in a format readily retrievable, a licensee shall maintain a single form which:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.01.04#N(1)">(1)</span> Indicates that a pharmacy is not conveniently available to the patient;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.01.04#N(2)">(2)</span> States that the determination that a pharmacy is not conveniently available was made solely by the patient; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.01.04#N(3)">(3)</span> Is signed and dated by the patient before dispensing prescription drugs to the patient for the first time.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.01.04#O">O.</span> A licensee shall display prominently a sign which informs the patient that prescription drugs can be purchased from the permit holder if the patient determines that a pharmacy is not conveniently available to the patient.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.01.04#P">P.</span> A licensee may not make any agreement that denies a patient a free choice of pharmacist or pharmacy services.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.01.04#Q">Q.</span> A licensee shall post a sign conspicuously positioned and readable regarding the process for resolving incorrectly filled prescriptions or includes written information regarding the process with each prescription dispensed.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.01.04#R">R.</span> A licensee shall maintain at all times the minimum professional and technical equipment and sanitary appliances that are necessary to prepare and dispense prescriptions properly.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.01.04#S">S.</span> To the extent permitted by <a class="internal-link no-wrap" href="/us/md/exec/comar/10.32.23" title="Chapter 23 Permits for the Dispensing of Prescription Drugs">COMAR 10.32.23</a>, a licensed physician may personally prepare and dispense a prescription written by:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.01.04#S(1)">(1)</span> A physician assistant with whom the physician has a delegation agreement that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.01.04#S(1)(a)">(a)</span> Complies with <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Title 15, Subtitle 3, Annotated Code of Maryland</a>; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.01.04#S(1)(b)">(b)</span> Permits the physician assistant to prescribe the drug; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.01.04#S(2)">(2)</span> A certified registered nurse practitioner who is:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.01.04#S(2)(a)">(a)</span> Authorized to practice under <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Title 8, Subtitle 3, Annotated Code of Maryland</a>; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.01.04#S(2)(b)">(b)</span> Working with the physician in the same practice.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.13.01.05" data-order="|10|13|01|.05|" data-ref-path="10|13|01|.05" class="h__section">.05 Inspection Requirements.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.01.05#A">A.</span> The Board of Dental Examiners, the Board of Physicians, and the Board of Podiatric Medical Examiners shall report annually to the Office of Controlled Substances Administration the names and addresses of its licensees who:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.01.05#A(1)">(1)</span> Are authorized to personally prepare and dispense prescription drugs; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.01.05#A(2)">(2)</span> Have reported to the appropriate Board that they have personally prepared and dispensed prescription drugs within the previous year.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.01.05#B">B.</span> A licensee shall allow the Office of Controlled Substances Administration to enter and inspect the licensee’s practice locations at all reasonable hours.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.01.05#C">C.</span> The Office of Controlled Substances Administration shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.01.05#C(1)">(1)</span> Enter and inspect the practice locations of a licensee who holds an initial dispensing permit:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.01.05#C(1)(a)">(a)</span> Within 6 months after receiving the annual report set forth in <a class="internal-link " href="/us/md/exec/comar/10.13.01.05#A(1)" title="">§A(1) of this regulation</a>; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.01.05#C(1)(b)">(b)</span> At least one more time during the duration of the permit;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.01.05#C(2)">(2)</span> If a licensee who holds an initial dispensing permit has more than one practice location:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.01.05#C(2)(a)">(a)</span> Enter and inspect a practice location of the licensee within 6 months after receiving the annual report set forth in <a class="internal-link " href="/us/md/exec/comar/10.13.01.05#A(1)" title="">§A(1) of this regulation</a>; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.01.05#C(2)(b)">(b)</span> Enter and inspect a different practice location at least one time during the duration of the permit;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.01.05#C(3)">(3)</span> If a licensee who holds a dispensing permit is seeking renewal:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.01.05#C(3)(a)">(a)</span> Enter and inspect a practice location of a licensee at least two times during the duration of the permit; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.01.05#C(3)(b)">(b)</span> If licensee has more than one practice location, enter and inspect two different practice locations during the duration of the permit;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.01.05#C(4)">(4)</span> If the Office of Controlled Substances Administration finds a deficiency at one practice location of a licensee with multiple practice locations, require the licensee to prepare, sign, and submit an affidavit attesting that all practice locations are in or will be in compliance as a result of the inspection;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.01.05#C(5)">(5)</span> Report to the Board of Pharmacy a wholesale distributor not licensed in Maryland; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.01.05#C(6)">(6)</span> Report the results of the inspections required under §C(1) and (2) of this regulation to the respective board of licensure.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.01.05#D">D.</span> A licensee shall sign and date an inspection form provided by the Office of Controlled Substances Administration relating to the requirements set forth in <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-102" title="">Health Occupations Article, §12-102, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.01.05#E">E.</span> A licensee shall pay a fee in an amount that will produce funds to approximate, but not exceed, the documented costs to the Office of Controlled Substances Administration for inspections, as required by the appropriate Board.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.01.05#F">F.</span> The Office of Controlled Substances Administration:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.01.05#F(1)">(1)</span> May suspend inspections of any physician who reports pursuant to <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-102" title="">Health Occupations Article, §12-102(c)(2)(ii)</a>4L, Annotated Code of Maryland, that the physician has not personally dispensed any prescription medications during the preceding year; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.01.05#F(2)">(2)</span> To the extent otherwise required by this regulation, shall resume inspections if that physician later reports that the physician has resumed dispensing activities.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.13.01.06" data-order="|10|13|01|.06|" data-ref-path="10|13|01|.06" class="h__section">.06 Failure to Comply with Dispensing Requirements.</h3>
                <p>A licensee who fails to comply with the requirements governing dispensing of prescription drugs shall have the dispensing permit revoked and be subject to disciplinary action by the appropriate licensing board.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.13.02" data-order="|10|13|02|" data-ref-path="10|13|02" class="h__chapter">Chapter 02 Purchase and Distribution of Prescription Drugs and Devices</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: August 22, 2011 (38:17 Md. R. 1012)</p>
                  <h3>Authority</h3>
                  <p>Health-General Article, §21-234; Health Occupations Article, §§<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-6" title="">12-6</a>C-<a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=01" title="">01</a>(u) and <a class="internal-link no-wrap" href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-6" title="">12-6</a>C-03.1; Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.13.02.01" data-order="|10|13|02|.01|" data-ref-path="10|13|02|.01" class="h__section">.01 Scope.</h3>
                <p>This chapter applies to the purchasing and distribution of prescription drugs and devices by the Department for public health purposes.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.13.02.02" data-order="|10|13|02|.02|" data-ref-path="10|13|02|.02" class="h__section">.02 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.02.02#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.02.02#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.02.02#B(1)">(1)</span> “Adulterated” means a drug or device where:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.02#B(1)(a)">(a)</span> Any part of the drug or device is filthy, putrid, or a decomposed substance; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.02#B(1)(b)">(b)</span> The drug or device was produced, prepared, packed, or held under unsanitary conditions that reasonably would be expected to have:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.13.02.02#B(1)(b)(i)">(i)</span> Contaminated the drug or device with filth; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.13.02.02#B(1)(b)(ii)">(ii)</span> Caused the drug or device to be injurious to health.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.02.02#B(2)">(2)</span> "Board" means the State Board of Pharmacy.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.02.02#B(3)">(3)</span> "Department" means the Maryland Department of Health.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.02.02#B(4)">(4)</span> “Misbranded” means a drug or device where:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.02#B(4)(a)">(a)</span> The drug’s or device’s:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.13.02.02#B(4)(a)(i)">(i)</span> Labeling is false or misleading in any way; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.13.02.02#B(4)(a)(ii)">(ii)</span> Labeling or packaging does not conform with Health-General Article, §21-248, Annotated Code of Maryland;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.02#B(4)(b)">(b)</span> The drug or device is in package form and does not bear a label that contains the name and place of business of the manufacturer, packer, or distributor;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.02#B(4)(c)">(c)</span> Any word, statement, or other information required under Health-General Article, Title 21, Subtitle 2, Annotated Code of Maryland, to appear on the drug’s or device’s labeling is not placed prominently on the labeling in a manner that is:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.13.02.02#B(4)(c)(i)">(i)</span> Conspicuous as compared with other words, statements, designs, or symbols on the labeling; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.13.02.02#B(4)(c)(ii)">(ii)</span> In terms likely to be read and understood by the ordinary individual under customary conditions of purchase and use;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.02#B(4)(d)">(d)</span> The drug’s or device’s labeling does not include, in whatever manner and form that may be necessary to protect the user of the drug or device, adequate directions for the use of the drug or device;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.02#B(4)(e)">(e)</span> The drug’s or device’s labeling does not include, in whatever manner and form that may be necessary to protect the user of the drug or device, adequate warnings against:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.13.02.02#B(4)(e)(i)">(i)</span> The use of the drug or device by anyone suffering from a pathological condition that may cause the drug’s or device’s use to be dangerous to health;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.13.02.02#B(4)(e)(ii)">(ii)</span> The use of the drug or device by a child if the use by a child may be dangerous; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.13.02.02#B(4)(e)(iii)">(iii)</span> Unsafe dosages, methods of administration, or duration of administration of the drug or device;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.02#B(4)(f)">(f)</span> The drug or device is dangerous to health when used in the dosage, with the frequency, or for the duration specified, recommended, or suggested in the labeling of the drug or device; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.02#B(4)(g)">(g)</span> The trademark, trade name, imprint, symbol, or other identifying mark of another drug or any likeness of any of these markings of another drug or device is placed on the drug or device or its container with the intent to defraud.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.02.02#B(5)">(5)</span> “Pedigree” means a record of the tracking of a drug or device through the supply chain, with each trading partner authenticating the drug or device upon receipt and transfer.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.02.02#B(6)">(6)</span> "Prescription device" means a device required by federal law or regulation to be dispensed only by a prescription.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.02.02#B(7)">(7)</span> Prescription Drug.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.02#B(7)(a)">(a)</span> "Prescription drug" means a drug required by federal law or regulation to be dispensed only by a prescription.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.02#B(7)(b)">(b)</span> "Prescription drug" includes:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.13.02.02#B(7)(b)(i)">(i)</span> A biological product; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.13.02.02#B(7)(b)(ii)">(ii)</span> Finished dosage forms and bulk drug substances subject to §503(b) of the Federal Food, Drug, and Cosmetic Act.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.02#B(7)(c)">(c)</span> "Prescription drug" does not include:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.13.02.02#B(7)(c)(i)">(i)</span> Blood and blood components intended for transfusion; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.13.02.02#B(7)(c)(ii)">(ii)</span> Biological products that are also medical devices.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.02.02#B(8)">(8)</span> "Public health purposes" includes the purpose of controlling communicable diseases or environmental health hazards.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.02.02#B(9)">(9)</span> "Secretary" means the Secretary of Health.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.13.02.03" data-order="|10|13|02|.03|" data-ref-path="10|13|02|.03" class="h__section">.03 Personnel.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.02.03#A">A.</span> The Secretary shall designate one or more Department employee representatives to be responsible for the purchase and distribution of prescription drugs and devices for public health purposes.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.02.03#B">B.</span> A designated Department representative shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.02.03#B(1)">(1)</span> Be a merit or contractual employee of the Department employed full time in a managerial level position;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.02.03#B(2)">(2)</span> Be aware of and knowledgeable about the policies and procedures pertaining to the purchase and distribution of prescription drugs and devices for public health purposes, including applicable State and federal laws;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.02.03#B(3)">(3)</span> Be actively involved in, and aware of, the daily operation of the Department’s purchasing and distribution of prescription drugs and prescription devices;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.02.03#B(4)">(4)</span> Be responsible for:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.03#B(4)(a)">(a)</span> Storage and handling as set forth in <a class="internal-link " href="/us/md/exec/comar/10.13.02.04" title=".04 Storage and Handling.">Regulation .04 of this chapter</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.03#B(4)(b)">(b)</span> Record-keeping requirements as set forth in <a class="internal-link " href="/us/md/exec/comar/10.13.02.06" title=".06 Record Keeping.">Regulation .06 of this chapter</a>; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.03#B(4)(c)">(c)</span> Making records available for inspection; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.02.03#B(5)">(5)</span> Meet the following qualifications:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.03#B(5)(a)">(a)</span> Is 21 years old or older;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.03#B(5)(b)">(b)</span> Except for an authorized absence such as sick leave or vacation leave, is physically present at the Department during regular business hours;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.03#B(5)(c)">(c)</span> Does not have any convictions for a violation of any federal, State, or local laws relating to wholesale or retail prescription drug distribution or distribution of controlled substances; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.03#B(5)(d)">(d)</span> Does not have any convictions for a felony under federal, State, or local laws.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.13.02.04" data-order="|10|13|02|.04|" data-ref-path="10|13|02|.04" class="h__section">.04 Storage and Handling.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.02.04#A">A.</span> Storage Facility. A designated Department representative shall store, hold, or handle prescription drugs and devices in a facility that:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.02.04#A(1)">(1)</span> Is constructed to facilitate:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.04#A(1)(a)">(a)</span> Cleaning; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.04#A(1)(b)">(b)</span> Maintenance;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.02.04#A(2)">(2)</span> Has storage areas designed to provide adequate:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.04#A(2)(a)">(a)</span> Equipment;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.04#A(2)(b)">(b)</span> Humidity control;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.04#A(2)(c)">(c)</span> Lighting;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.04#A(2)(d)">(d)</span> Sanitation;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.04#A(2)(e)">(e)</span> Security conditions;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.04#A(2)(f)">(f)</span> Space;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.04#A(2)(g)">(g)</span> Temperature; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.04#A(2)(h)">(h)</span> Ventilation;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.02.04#A(3)">(3)</span> Has a secured separate quarantine area for storage of prescription drugs or devices that are:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.04#A(3)(a)">(a)</span> Adulterated;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.04#A(3)(b)">(b)</span> Damaged;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.04#A(3)(c)">(c)</span> Deteriorated;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.04#A(3)(d)">(d)</span> In immediate or sealed secondary containers that have been opened;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.04#A(3)(e)">(e)</span> Misbranded; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.04#A(3)(f)">(f)</span> Outdated;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.02.04#A(4)">(4)</span> Is maintained in a clean and orderly condition; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.02.04#A(5)">(5)</span> Is free from insects, rodents, birds, or vermin.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.02.04#B">B.</span> Storage.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.02.04#B(1)">(1)</span> A designated Department representative shall store a prescription drug or device at appropriate temperatures and under appropriate conditions in accordance with requirements:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.04#B(1)(a)">(a)</span> If any, on the labeling of the prescription drug or device; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.04#B(1)(b)">(b)</span> Set forth in the current edition of an official compendium, such as the United States Pharmacopeia/National Formulary (USP/NF).</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.02.04#B(2)">(2)</span> If no storage requirements are established for a prescription drug or device, a designated Department representative shall hold the prescription drug or device at a controlled room temperature, as defined in an official compendium as set forth in <a class="internal-link " href="/us/md/exec/comar/10.13.02.04#B(1)(b)" title="">§B(1)(b) of this regulation</a> to help assure that its identity, strength, quality, and purity are not adversely affected.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.02.04#B(3)">(3)</span> A designated Department representative shall document proper storage of prescription drugs and devices in accordance with the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.04#B(3)(a)">(a)</span> Use of manual, electromechanical, or electronic temperature and humidity recording equipment, devices, and logs; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.04#B(3)(b)">(b)</span> Record-keeping requirements in <a class="internal-link " href="/us/md/exec/comar/10.13.02.06" title=".06 Record Keeping.">Regulation .06 of this chapter</a> for stored prescription drugs and devices.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.02.04#C">C.</span> Examination of Materials.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.02.04#C(1)">(1)</span> Upon receipt of a prescription drug or device, a designated Department representative shall visually examine each outside shipping container to prevent the acceptance of:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.04#C(1)(a)">(a)</span> An adulterated prescription drug or device; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.04#C(1)(b)">(b)</span> A prescription drug or device that is otherwise unfit for distribution.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.02.04#C(2)">(2)</span> A designated Department representative shall examine each prescription drug or device container, as required under <a class="internal-link " href="/us/md/exec/comar/10.13.02.04#C(1)" title="">§C(1) of this regulation</a>, to ascertain whether there is any damage to the container that would suggest possible contamination or other damage to the contents.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.02.04#C(3)">(3)</span> A designated Department representative shall carefully inspect each outgoing shipment:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.04#C(3)(a)">(a)</span> For identity of the prescription drug or device being shipped; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.04#C(3)(b)">(b)</span> To ensure that there is no delivery of a prescription drug or device that has been damaged in storage or held under improper conditions.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.02.04#C(4)">(4)</span> Each unit of the Department, such as a local health department, that receives delivery of the prescription drug or device shall meet the requirements of this regulation for storage, security, and record keeping.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.02.04#C(5)">(5)</span> A designated Department representative shall follow the record-keeping requirements in <a class="internal-link " href="/us/md/exec/comar/10.13.02.06" title=".06 Record Keeping.">Regulation .06 of this chapter</a> for an incoming and an outgoing prescription drug or device.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.02.04#D">D.</span> Security of the Storage Area. A designated Department representative shall ensure that the area where prescription drugs and devices are stored is secure from unauthorized entry as follows:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.02.04#D(1)">(1)</span> Access from outside the premises is:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.04#D(1)(a)">(a)</span> Kept to a minimum; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.04#D(1)(b)">(b)</span> Limited to authorized personnel as determined by the designated Department representative; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.02.04#D(2)">(2)</span> The storage area is equipped with:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.04#D(2)(a)">(a)</span> A security system that provides protection against theft and diversion;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.04#D(2)(b)">(b)</span> An inventory management and control system that protects against, detects, and documents any instances of theft, diversion, or counterfeiting; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.04#D(2)(c)">(c)</span> A security system that protects the integrity and confidentiality of data and documents.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.02.04#E">E.</span> Authorized Access of Storage Area. A designated Department representative shall ensure that the area where prescription drugs and devices are stored:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.02.04#E(1)">(1)</span> Has a means in place to make the data and documentation required under this chapter readily available to the Board, an agent of the Board, or federal or State law enforcement officials; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.02.04#E(2)">(2)</span> Allows for inspection by a Board representative.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.13.02.05" data-order="|10|13|02|.05|" data-ref-path="10|13|02|.05" class="h__section">.05 Quarantine, Destruction, and Return of Prescription Drugs and Devices.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.02.05#A">A.</span> A designated Department representative shall quarantine and physically separate prescription drugs and devices that are outdated, damaged, deteriorated, misbranded, or adulterated from other prescription drugs and devices until the quarantined and separated prescription drugs and devices are destroyed or returned to their supplier for disposal.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.02.05#B">B.</span> A designated Department representative shall identify, mark, quarantine, and physically separate from other prescription drugs and devices those prescription drugs and devices whose immediate or sealed outer or sealed secondary containers have been opened or used, until the prescription drugs and devices are either destroyed or returned to their supplier for disposal.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.02.05#C">C.</span> Prescription Drugs.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.02.05#C(1)">(1)</span> If the conditions under which a prescription drug has been returned by a local health department or a health care provider cast doubt on the prescription drug's safety, identity, strength, quality, or purity, then a designated Department representative shall destroy the prescription drug or return the prescription drug to the supplier, unless examination, testing, or other investigation proves that the prescription drug meets appropriate standards of safety, identity, strength, quality, and purity.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.02.05#C(2)">(2)</span> In determining whether the conditions under which a prescription drug has been returned by a local health department or a health care provider cast doubt on the prescription drug's safety, identity, strength, quality, or purity, a designated Department representative shall consider, at a minimum, the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.05#C(2)(a)">(a)</span> Conditions under which the prescription drug has been held, stored, or shipped before or during the return of the prescription drug; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.05#C(2)(b)">(b)</span> Condition of the prescription drug and its container, carton, or labeling, as a result of storage or shipping.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.02.05#D">D.</span> Prescription Devices.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.02.05#D(1)">(1)</span> If the conditions under which a prescription device has been returned cast doubt on the prescription device's safety, identity, or quality, then a designated Department representative shall destroy or return the prescription device to the supplier, unless examination, testing, or other investigation proves that the prescription device meets appropriate standards of safety, identity, strength, and quality.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.02.05#D(2)">(2)</span> In determining whether the conditions under which a prescription device has been returned by a local health department or a health care provider cast doubt on the prescription device's safety, identity, or quality, a designated Department representative shall consider, at a minimum, the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.05#D(2)(a)">(a)</span> Conditions under which the prescription device has been held, stored, or shipped before or during return of the prescription device; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.05#D(2)(b)">(b)</span> Condition of the prescription device and the device’s container, carton, or labeling, as a result of storage or shipping.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.02.05#E">E.</span> A designated Department representative shall follow the record-keeping requirements in <a class="internal-link " href="/us/md/exec/comar/10.13.02.06" title=".06 Record Keeping.">Regulation .06 of this chapter</a> for outdated, damaged, deteriorated, misbranded, or adulterated prescription drugs and devices.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.13.02.06" data-order="|10|13|02|.06|" data-ref-path="10|13|02|.06" class="h__section">.06 Record Keeping.</h3>
                <p>A designated Department representative shall:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.02.06#A">A.</span> Establish and maintain inventories and records of transactions regarding the receipt and distribution or other disposition of prescription drugs and devices;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.02.06#B">B.</span> Include the following information in the records required under <a class="internal-link " href="/us/md/exec/comar/10.13.02.06#A" title="">§A of this regulation</a>:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.02.06#B(1)">(1)</span> The source of a prescription drug or device, including the:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.06#B(1)(a)">(a)</span> Name and principal address of the seller or transferor; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.06#B(1)(b)">(b)</span> Address of the location from which a prescription drug or device was shipped;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.02.06#B(2)">(2)</span> The identity and quantity of the prescription drugs and devices received and distributed or disposed of;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.02.06#B(3)">(3)</span> The dates of receipt and distribution or other disposition of the prescription drugs and devices; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.02.06#B(4)">(4)</span> If required by <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-6" title="">Health Occupations Article, §12-6</a>C-10, Annotated Code of Maryland, the pedigrees for prescription drugs that are wholesale distributed outside the normal distribution channel;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.02.06#C">C.</span> Establish, maintain, and adhere to written policies and procedures addressing the:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.02.06#C(1)">(1)</span> Receipt, security, storage, inventory, and distribution of prescription drugs and devices;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.02.06#C(2)">(2)</span> Identifying, recording, and reporting of losses or thefts; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.02.06#C(3)">(3)</span> Correcting of errors and inaccuracies in inventories;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.02.06#D">D.</span> Include in the written policies and procedures established according to <a class="internal-link " href="/us/md/exec/comar/10.13.02.06#C" title="">§C of this regulation</a> the following:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.02.06#D(1)">(1)</span> A procedure by which the oldest approved and unexpired stock of a prescription drug or device is distributed first;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.02.06#D(2)">(2)</span> Procedures to be followed for handling a recall and withdrawal of a prescription drug or device due to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.06#D(2)(a)">(a)</span> An action initiated at the request of the United States Food and Drug Administration (FDA) or other federal, State, or local law enforcement or other government agency, including the Maryland Division of Drug Control;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.06#D(2)(b)">(b)</span> A voluntary action by the manufacturer to remove a defective or potentially defective prescription drug or device from the market; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.06#D(2)(c)">(c)</span> An action undertaken to promote public health and safety by replacing existing merchandise with an improved product or new package design;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.02.06#D(3)">(3)</span> A procedure to ensure that the Department is prepared for, protected against, and able to handle a crisis that affects security or operation of a facility if any of the following situations occur:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.06#D(3)(a)">(a)</span> Strike;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.06#D(3)(b)">(b)</span> Fire;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.06#D(3)(c)">(c)</span> Flood;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.06#D(3)(d)">(d)</span> Catastrophic health emergency as defined in <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gps&amp;section=14-3" title="">Public Safety Article, §14-3</a>A-01, Annotated Code of Maryland;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.06#D(3)(e)">(e)</span> Terrorist activities;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.06#D(3)(f)">(f)</span> Natural disaster; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.06#D(3)(g)">(g)</span> Other situations of local, State, or national emergency;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.02.06#D(4)">(4)</span> A procedure to ensure that outdated prescription drugs and devices are segregated from other prescription drugs and devices and either returned to the manufacturer or destroyed;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.02.06#D(5)">(5)</span> A procedure for:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.06#D(5)(a)">(a)</span> The disposing and destruction of containers, labels, and packaging to ensure that the containers, labels, and packaging cannot be used in counterfeiting activities; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.06#D(5)(b)">(b)</span> Appropriate witnessing of the destruction of any labels, packaging, immediate containers, or containers in accordance with applicable federal and State requirements; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.02.06#D(6)">(6)</span> A procedure for:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.06#D(6)(a)">(a)</span> Identifying, investigating, and reporting prescription drug inventory discrepancies involving counterfeiting, suspicion of counterfeiting, contraband, or suspicion of contraband; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.02.06#D(6)(b)">(b)</span> Upon discovery, the reporting of a discrepancy within 5 business days to the Board;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.02.06#E">E.</span> Make available inventories and records for inspection and copying by authorized federal or State law enforcement agency officials for a period of 3 years after the date of creation of the inventories and records;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.02.06#F">F.</span> Keep the records described in this regulation readily available for inspection by authorized federal, State, or local law enforcement agency officials during the retention period, either:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.02.06#F(1)">(1)</span> At the inspection site; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.02.06#F(2)">(2)</span> So as to be immediately retrievable by computer or other electronic means;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.02.06#G">G.</span> Within 5 working days of a request by an authorized official of a federal, State, or local law enforcement agency, make available for inspection records kept at a central location apart from the inspection site and not electronically retrievable;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.02.06#H">H.</span> Establish and maintain procedures for reporting counterfeit and contraband or suspected counterfeit and contraband drugs or devices or counterfeiting and contraband or suspected counterfeiting and contraband activities to the Board and the FDA;</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.02.06#I">I.</span> Maintain a system for the mandatory reporting of significant inventory losses of prescription drugs and devices where it is known or suspected that diversion is occurring to:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.02.06#I(1)">(1)</span> The Board;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.02.06#I(2)">(2)</span> The FDA; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.02.06#I(3)">(3)</span> Where applicable, the U.S. Drug Enforcement Administration; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.02.06#J">J.</span> Consider the following factors when determining if there has been a significant inventory loss:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.02.06#J(1)">(1)</span> The schedule of the missing items;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.02.06#J(2)">(2)</span> The abuse or misuse potential of the missing items;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.02.06#J(3)">(3)</span> The abuse or misuse potential in the Department’s area of the missing substance;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.02.06#J(4)">(4)</span> The quantity missing in relation to the total quantity purchased, for example, one tablet per</p>
                <p>one bottle or container;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.02.06#J(5)">(5)</span> Whether this is the first time a potentially significant inventory loss has occurred;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.02.06#J(6)">(6)</span> Whether this loss was reported to local law enforcement authorities; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.02.06#J(7)">(7)</span> Whether there is a significant resale value of the missing items.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.13.03" data-order="|10|13|03|" data-ref-path="10|13|03" class="h__chapter">Chapter 03 Guidelines for Co-Prescribing Opioid Overdose Reversal Drugs</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: June 17, 2019 (46:12 Md. R. 544)</p>
                  <h3>Authority</h3>
                  <p>Health-General Article, §§2-104(b), 13-3501, and 13-3502, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.13.03.01" data-order="|10|13|03|.01|" data-ref-path="10|13|03|.01" class="h__section">.01 Scope.</h3>
                <p>This chapter applies to all licensed health care practitioners who may prescribe an opioid overdose reversal drug to an individual who:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.03.01#A">A.</span> May be at an elevated risk of experiencing an opioid overdose including, but not limited to, an individual who:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.03.01#A(1)">(1)</span> Is receiving an opioid for chronic pain;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.03.01#A(2)">(2)</span> Is receiving an opioid and a prescription for a benzodiazepine; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.03.01#A(3)">(3)</span> Has an opioid use disorder; or</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.03.01#B">B.</span> Resides or spends time with an individual who:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.03.01#B(1)">(1)</span> Is prescribed opioids;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.03.01#B(2)">(2)</span> Misuses opioids; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.03.01#B(3)">(3)</span> Has an opioid use disorder.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.13.03.02" data-order="|10|13|03|.02|" data-ref-path="10|13|03|.02" class="h__section">.02 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.03.02#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.03.02#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.03.02#B(1)">(1)</span> “Co–prescribed” means, with respect to an opioid overdose reversal drug, the practice of prescribing the drug in conjunction with an opioid prescription for a patient at an elevated risk of overdose.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.03.02#B(2)">(2)</span> “Department” means the Maryland Department of Health.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.03.02#B(3)">(3)</span> “Monitored prescription drug” means a prescription drug that contains a Schedule II, Schedule III, Schedule IV, or Schedule V controlled dangerous substance designated under <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gcr/gcr.pdf" title="">Criminal Law Article, Title 5, Subtitle 4, Annotated Code of Maryland</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.03.02#B(4)">(4)</span> “Opioid overdose reversal drug” means a drug that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.03.02#B(4)(a)">(a)</span> Rapidly reverses the respiratory depressant effects of an opioid medication; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.03.02#B(4)(b)">(b)</span> Is approved by the federal Food and Drug Administration for the treatment of a known or suspected opioid overdose.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.03.02#B(5)">(5)</span> “Prescribing licensed health care provider” means an individual who is authorized by law to prescribe a monitored prescription drug.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.03.02#B(6)">(6)</span> “Risk factor” means a characteristic, condition, behavior, or any variable that increases the likelihood of developing a disease or injury.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.03.02#B(7)">(7)</span> “Secretary” means the Secretary of the Maryland Department of Health.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.03.02#B(8)">(8)</span> Targeted Patient Population.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.03.02#B(8)(a)">(a)</span> “Targeted patient population” means an individual likely to experience or witness an opioid overdose.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.03.02#B(8)(b)">(b)</span> “Targeted patient population” includes, but is not limited to, an individual who:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.13.03.02#B(8)(b)(i)">(i)</span> Is being prescribed opioids for acute, if appropriate, or chronic pain;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.13.03.02#B(8)(b)(ii)">(ii)</span> Is being treated for an opioid use disorder;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.13.03.02#B(8)(b)(iii)">(iii)</span> Is receiving a prescription for an opioid and a benzodiazepine; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.13.03.02#B(8)(b)(iv)">(iv)</span> Resides or spends time with an individual who is prescribed opioids, misuses opioids, or has an opioid use disorder.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.13.03.03" data-order="|10|13|03|.03|" data-ref-path="10|13|03|.03" class="h__section">.03 General Provisions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.03.03#A">A.</span> When determined appropriate by the prescribing licensed health care provider, targeted patient populations may be co-prescribed an opioid overdose reversal drug, if the individual is at an elevated risk of experiencing an opioid overdose by virtue of belonging to one or more categories of the targeted patient population.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.03.03#B">B.</span> Responsibilities of the Prescribing Licensed Health Care Provider.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.03.03#B(1)">(1)</span> Risk Monitoring.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.03.03#B(1)(a)">(a)</span> It is suggested that the licensed health care provider routinely assess patients for their risk of being likely to experience or witness an opioid overdose.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.03.03#B(1)(b)">(b)</span> The prescriber may utilize additional sources of information for determining a patient’s opioid overdose risk including, but not limited to:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.13.03.03#B(1)(b)(i)">(i)</span> Checking the Maryland Prescription Drug Monitoring Program;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.13.03.03#B(1)(b)(ii)">(ii)</span> Reviewing medical records; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.13.03.03#B(1)(b)(iii)">(iii)</span> Soliciting family input, if appropriate.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.03.03#B(2)">(2)</span> Education. If a patient is assessed to be at risk of an opioid overdose, the prescriber may educate the patient about, including but not limited to, the following areas:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.03.03#B(2)(a)">(a)</span> The risks of an opioid overdose; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.03.03#B(2)(b)">(b)</span> How to identify and respond to an opioid overdose.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.03.03#B(3)">(3)</span> Documentation. Licensed health care providers should document education and clinical services related to the provision of an opioid overdose reversal drug in their patients’ medical records in accordance with the standard of care.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.13.03.04" data-order="|10|13|03|.04|" data-ref-path="10|13|03|.04" class="h__section">.04 Additional Guidelines.</h3>
                <p>The Secretary may make the following additional clinical guidance available on the Department’s website:</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.03.04#A">A.</span> Any available opioid overdose reversal drug formulations, corresponding prescribing templates, and any standing order for these drugs; and</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.03.04#B">B.</span> Any other applicable information deemed necessary by the Secretary.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.13.04" data-order="|10|13|04|" data-ref-path="10|13|04" class="h__chapter">Chapter 04 Emergency Use Auto-Injectable Epinephrine Program</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: May 20, 2019 (46:10 Md. R. 487)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.13.04.01" title=".01 Scope.">Regulation .01</a> amended effective July 12, 2021 (48:14 Md. R. 538)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.13.04.02#B" title="">Regulation .02B</a> amended effective July 12, 2021 (48:14 Md. R. 538)</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.13.04.03" title=".03 Emergency Epinephrine.">Regulation .03</a> amended effective July 12, 2021 (48:14 Md. R. 538)</p>
                  <h3>Authority</h3>
                  <p>Health-General Article, §§2-104 and 13-7A-03, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.13.04.01" data-order="|10|13|04|.01|" data-ref-path="10|13|04|.01" class="h__section">.01 Scope.</h3>
                <p>This chapter applies to employees of food service, recreation, or wellness facilities on the premises of an institution of higher education as defined in <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=ged&amp;section=10-101" title="">Education Article, §10-101, Annotated Code of Maryland</a>, and employees of food service facilities, as defined in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.15.03" title="Chapter 03 Food Service Facilities">COMAR 10.15.03</a>, who voluntarily participate in the Program.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.13.04.02" data-order="|10|13|04|.02|" data-ref-path="10|13|04|.02" class="h__section">.02 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.04.02#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.04.02#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.04.02#B(1)">(1)</span> “Affiliated individual” means an individual who is 18 years old or older who has been designated in writing by a participating facility to serve either as a health supervisor or as a certificate holder.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.04.02#B(2)">(2)</span> “Agent” means an individual who:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.04.02#B(2)(a)">(a)</span> Is 18 years old or older;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.04.02#B(2)(b)">(b)</span> Has successfully completed, at the expense of the participating facility, an emergency epinephrine educational training program approved by the Department; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.04.02#B(2)(c)">(c)</span> Is designated in writing by a certificate holder to administer auto-injectable epinephrine in an emergency situation.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.04.02#B(3)">(3)</span> “Anaphylaxis” means a sudden, severe, and potentially life–threatening allergic reaction that occurs when an individual is exposed to an allergen.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.04.02#B(4)">(4)</span> “Applicant” means an individual applying for a Certificate for Emergency Epinephrine.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.04.02#B(5)">(5)</span> “Auto-injectable epinephrine” means a portable, disposable drug delivery device that contains a premeasured single dose of epinephrine that is used to treat anaphylaxis in an emergency situation.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.04.02#B(6)">(6)</span> “Certificate for emergency epinephrine” means a certificate issued by the Maryland Department of Health to an individual employed or designated by a participating facility to obtain, store, and administer auto-injectable epinephrine.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.04.02#B(7)">(7)</span> “Certificate holder” means an individual who is authorized by the Maryland Department of Health to obtain, store, and administer auto-injectable epinephrine to be used in an emergency situation.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.04.02#B(8)">(8)</span> “Department” means the Maryland Department of Health.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.04.02#B(9)">(9)</span> “Eligible institution” means an institution of higher education that has a food service facility or a recreation and wellness facility on the premises and that otherwise meets the requirements of this chapter.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.04.02#B(10)">(10)</span> “Food service facility” has the meaning stated in <a class="internal-link no-wrap" href="/us/md/exec/comar/10.15.03" title="Chapter 03 Food Service Facilities">COMAR 10.15.03</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.04.02#B(11)">(11)</span> “Health supervisor” means an individual who:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.04.02#B(11)(a)">(a)</span> Provides health services for a participating facility; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.04.02#B(11)(b)">(b)</span> Is licensed by the State as a:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.13.04.02#B(11)(b)(i)">(i)</span> Physician;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.13.04.02#B(11)(b)(ii)">(ii)</span> Certified nurse practitioner; or</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.13.04.02#B(11)(b)(iii)">(iii)</span> Registered nurse.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.04.02#B(12)">(12)</span> “Participating facility” means a recreation or wellness facility at an eligible institution or a food service facility, including a food service facility at an eligible institution, in the State that voluntarily participates in the Program.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.04.02#B(13)">(13)</span> “Successfully completed” means to pass a written examination with a grade of 75 percent or higher.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.13.04.03" data-order="|10|13|04|.03|" data-ref-path="10|13|04|.03" class="h__section">.03 Emergency Epinephrine.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.04.03#A">A.</span> An individual may apply, on a form prescribed by the Department, for a certificate for emergency epinephrine, which shall be valid for up to 1 year if the applicant:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.04.03#A(1)">(1)</span> Is employed by a participating facility;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.04.03#A(2)">(2)</span> Is 18 years old or older; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.04.03#A(3)">(3)</span> Has successfully completed, at the expense of the participating facility, an emergency epinephrine educational training program approved by the Department.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.04.03#B">B.</span> The applicant shall submit to the Department with the form required in <a class="internal-link " href="/us/md/exec/comar/10.13.04.03#A" title="">§A of this regulation</a> a written policy that includes:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.04.03#B(1)">(1)</span> Designation of agents and affiliated individuals;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.04.03#B(2)">(2)</span> The name of the approved emergency epinephrine educational training program; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.04.03#B(3)">(3)</span> Procedures to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.04.03#B(3)(a)">(a)</span> Store emergency auto-injectable epinephrine;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.04.03#B(3)(b)">(b)</span> Maintain the emergency auto-injectable epinephrine in a secure manner;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.04.03#B(3)(c)">(c)</span> Report use of emergency auto-injectable epinephrine according to <a class="internal-link " href="/us/md/exec/comar/10.13.04.03#L" title="">§L of this regulation</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.04.03#B(3)(d)">(d)</span> Train an emergency epinephrine certificate holder and agent annually; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.04.03#B(3)(e)">(e)</span> Maintain documentation of an emergency epinephrine certificate holder and agent training for 3 years.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.04.03#C">C.</span> A provider of an emergency epinephrine educational training program shall meet the requirements of <a class="internal-link no-wrap" href="/us/md/exec/comar/10.16.07.15#C" title="">COMAR 10.16.07.15C</a> and D.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.04.03#D">D.</span> An individual teaching an emergency epinephrine educational training program shall be licensed as a physician, a registered nurse, or a certified nurse practitioner.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.04.03#E">E.</span> The Department shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.04.03#E(1)">(1)</span> Issue a certificate for emergency epinephrine to an applicant who meets the requirements in §§A and B of this regulation;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.04.03#E(2)">(2)</span> Deny the issuance of a certificate for emergency epinephrine to an applicant who does not meet the requirements in §§A and B of this regulation;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.04.03#E(3)">(3)</span> Revoke or suspend the certificate for emergency epinephrine of an individual who does not meet the requirements in §§A and B of this regulation;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.04.03#E(4)">(4)</span> Approve an emergency epinephrine educational training program if the training program meets the requirements of <a class="internal-link " href="/us/md/exec/comar/10.13.04.03#C" title="">§C of this regulation</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.04.03#E(5)">(5)</span> Disapprove an emergency epinephrine educational training program if the training program does not meet the requirement of <a class="internal-link " href="/us/md/exec/comar/10.13.04.03#C" title="">§C of this regulation</a>; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.04.03#E(6)">(6)</span> On or before January 31 of each year, publish a report summarizing the information obtained from the reported uses of emergency auto-injectable epinephrine at participating facilities according to <a class="internal-link " href="/us/md/exec/comar/10.13.04.03#L" title="">§L of this regulation</a>.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.04.03#F">F.</span> A physician licensed to practice medicine in the State may prescribe auto-injectable epinephrine in the name of a certificate holder.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.04.03#G">G.</span> A pharmacist licensed to practice pharmacy in the State, or a physician, may dispense auto-injectable epinephrine under a prescription issued to a certificate holder.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.04.03#H">H.</span> A certificate holder may:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.04.03#H(1)">(1)</span> On presentment of a certificate for emergency epinephrine, receive from any physician licensed to practice medicine in the State a prescription for auto-injectable epinephrine; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.04.03#H(2)">(2)</span> Possess and store prescribed auto-injectable epinephrine.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.04.03#I">I.</span> A participating facility:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.04.03#I(1)">(1)</span> Shall ensure that there is a written plan for the emergency epinephrine program that:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.04.03#I(1)(a)">(a)</span> Is approved annually, in writing, by a health supervisor;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.04.03#I(1)(b)">(b)</span> Is on file at the participating facility and is available for inspection; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.04.03#I(1)(c)">(c)</span> Includes at a minimum:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.13.04.03#I(1)(c)(i)">(i)</span> The name, title, and license number of the health supervisor;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.13.04.03#I(1)(c)(ii)">(ii)</span> Information on the emergency epinephrine educational training program used;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.13.04.03#I(1)(c)(iii)">(iii)</span> Procedures for disseminating information to staff on the emergency epinephrine program;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.13.04.03#I(1)(c)(iv)">(iv)</span> Procedures for the proper storage and handling of medication;</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.13.04.03#I(1)(c)(v)">(v)</span> Procedures for the use of emergency services and 911 services; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.13.04.03#I(1)(c)(vi)">(vi)</span> Procedures for documenting incidents involving the administration of auto-injectable epinephrine by a certificate holder in accordance with <a class="internal-link " href="/us/md/exec/comar/10.13.04.03#L" title="">§L of this regulation</a>;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.04.03#I(2)">(2)</span> Shall ensure that a certificate holder who is employed by, or a designated affiliated individual of, the participating facility complies with all provisions of this chapter;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.04.03#I(3)">(3)</span> Shall provide the Department with access to records and documents required under this chapter;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.04.03#I(4)">(4)</span> Shall designate in writing the certificate holders who will be responsible for the storage, maintenance, and control of the supply of auto-injectable epinephrine;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.04.03#I(5)">(5)</span> May not obtain or store auto-injectable epinephrine unless the participating facility has at least two certificate holders; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.04.03#I(6)">(6)</span> Shall maintain a copy of the certificate issued to a certificate holder under <a class="internal-link " href="/us/md/exec/comar/10.13.04.03#E" title="">§E of this regulation</a> for at least 3 years.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.04.03#J">J.</span> Certificate Holders.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.04.03#J(1)">(1)</span> Subject to <a class="internal-link " href="/us/md/exec/comar/10.13.04.03#I(4)" title="">§I(4) of this regulation</a>, a certificate holder may obtain:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.04.03#J(1)(a)">(a)</span> A prescription for a supply of auto-injectable epinephrine from a licensed physician as provided in <a class="internal-link " href="/us/md/exec/comar/10.13.04.03#F" title="">§F of this regulation</a>; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.04.03#J(1)(b)">(b)</span> A supply of auto-injectable epinephrine from a licensed pharmacist or a licensed physician as provided in <a class="internal-link " href="/us/md/exec/comar/10.13.04.03#G" title="">§G of this regulation</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.04.03#J(2)">(2)</span> A certificate holder shall store a supply of auto-injectable epinephrine obtained under <a class="internal-link " href="/us/md/exec/comar/10.13.04.03#J(1)" title="">§J(1) of this regulation</a>:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.04.03#J(2)(a)">(a)</span> In accordance with the manufacturer’s instructions; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.04.03#J(2)(b)">(b)</span> In a location that is readily accessible to certificate holders and agents in an emergency situation.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.04.03#K">K.</span> In an emergency situation when physician or emergency medical services are not immediately available, a certificate holder or agent may administer auto-injectable epinephrine to an individual who is experiencing or believed in good faith by the certificate holder or agent to be experiencing anaphylaxis.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.04.03#L">L.</span> A participating facility shall ensure that an incident that occurred on the premises of the facility that involved the administration of auto-injectable epinephrine by a certificate holder or agent is reported:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.04.03#L(1)">(1)</span> Immediately to the health supervisor and, in the case of a minor, to the minor’s parent or guardian; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.04.03#L(2)">(2)</span> To the Department within 5 business days of the incident on a form prescribed by the Department.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.13.05" data-order="|10|13|05|" data-ref-path="10|13|05" class="h__chapter">Chapter 05 AIDS Education Program for Persons Convicted of Drug/Sex-Related Crimes</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: June 17, 1955</p>
                  <p>Chapter "Purchase of Exempt Narcotic Preparations" repealed effective August 25, 1978 (5:17 Md. R. 1329)</p>
                  <p>——————</p>
                  <p>Regulations .01—.06 "AIDS Education Program for Persons Convicted of Drug/Sex-Related Crimes" adopted effective October 12, 1992 (19:20 Md. R. 1815)</p>
                  <p>Regulation .02B amended effective January 12, 2001 (28:1 Md. R. 26)</p>
                  <p>——————</p>
                  <p>Chapter repealed effective March 26, 2018 (45:6 Md. R. 320)</p>
                </section>
                <h2 id="/us/md/exec/comar/10.13.06" data-order="|10|13|06|" data-ref-path="10|13|06" class="h__chapter">Chapter 06 Acceptance of Oral Prescriptions for Certain Narcotic Drugs</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: November 10, 1955</p>
                  <p>Chapter repealed effective August 25, 1978 (5:17 Md. R. 1330)</p>
                </section>
                <h2 id="/us/md/exec/comar/10.13.07" data-order="|10|13|07|" data-ref-path="10|13|07" class="h__chapter">Chapter 07 Sale of Dihydrocodeinone or any of its Salts</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: April 1, 1960</p>
                  <p>Chapter repealed effective August 25, 1978 (5:17 Md. R. 1330)</p>
                </section>
                <h2 id="/us/md/exec/comar/10.13.08" data-order="|10|13|08|" data-ref-path="10|13|08" class="h__chapter">Chapter 08 Sale of Needles and Syringes or Other Paraphernalia</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: December 21, 1970</p>
                  <p><a class="internal-link no-wrap" href="/us/md/exec/comar/10.13.08.01" title=".01 Identification of Purchaser, and Record of Sale.">Regulation .01</a> amended effective March 6, 2000 (27:4 Md. R. 454)</p>
                  <h3>Authority</h3>
                  <p>Health-General Article, §2-104(b), Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.13.08.01" data-order="|10|13|08|.01|" data-ref-path="10|13|08|.01" class="h__section">.01 Identification of Purchaser, and Record of Sale.</h3>
                <p>The sale of needles and syringes or other paraphernalia shall be made by the pharmacist only in good faith to patients showing proper identification and indication of need.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.13.09" data-order="|10|13|09|" data-ref-path="10|13|09" class="h__chapter">Chapter 09 Sale of Nitrous Oxide</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: September 21, 1971</p>
                  <p>Regulations .01—.03 repealed effective January 21, 1991 (18:1 Md. R. 29)</p>
                </section>
                <h2 id="/us/md/exec/comar/10.13.10" data-order="|10|13|10|" data-ref-path="10|13|10" class="h__chapter">Chapter 10 Prescribing, Administering, and Dispensing of Amphetamines and Methamphetamines</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: August 7, 1973</p>
                  <p>Chapter revised effective July 13, 1979 (6:14 Md. R. 1207)</p>
                  <p>Chapter revised effective January 21, 1991 (18:1 Md. R. 29)</p>
                  <p>——————</p>
                  <p>Chapter repealed effective December 18, 1995 (22:25 Md. R. 1962)</p>
                </section>
                <h2 id="/us/md/exec/comar/10.13.11" data-order="|10|13|11|" data-ref-path="10|13|11" class="h__chapter">Chapter 11 Sale of Drugs by Vending Machine</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: October 10, 1994 (21:20 Md. R. 1732)</p>
                  <h3>Authority</h3>
                  <p>Health-General Article, §21-1111(c), Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.13.11.01" data-order="|10|13|11|.01|" data-ref-path="10|13|11|.01" class="h__section">.01 Exemption to Allow Sale of Drugs in Vending Machine.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.11.01#A">A.</span> A person may sell by vending machine or other similar device, nonprescription drugs that alleviate pain in the quantities and form specified in <a class="internal-link " href="/us/md/exec/comar/10.13.11.01#B" title="">§B of this regulation</a>, and which are exempted from the prohibition of Health-General Article, §21-1111, Annotated Code of Maryland.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.11.01#B">B.</span> Nonprescription drugs that alleviate pain may be sold by vending machine or other similar devices in:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.11.01#B(1)">(1)</span> Solid oral dosage form only; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.11.01#B(2)">(2)</span> Single dose quantities of not more than three tablets or capsules per dose.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h2 id="/us/md/exec/comar/10.13.12" data-order="|10|13|12|" data-ref-path="10|13|12" class="h__chapter">Chapter 12 Impoundment and Disposal of Drugs and Prescription Records</h2>
                <section class="line-group annotations">
                  <h3>Administrative History</h3>
                  <p>Effective date: June 24, 2002  (29:12 Md. R. 927)</p>
                  <h3>Authority</h3>
                  <p>Health-General Article, §21-1113, Annotated Code of Maryland</p>
                </section>
                <h3 id="/us/md/exec/comar/10.13.12.01" data-order="|10|13|12|.01|" data-ref-path="10|13|12|.01" class="h__section">.01 Definitions.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.12.01#A">A.</span> In this chapter, the following terms have the meanings indicated.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.12.01#B">B.</span> Terms Defined.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.12.01#B(1)">(1)</span> "Authorized prescriber" means:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.12.01#B(1)(a)">(a)</span> A licensed dentist, licensed physician, licensed podiatrist, licensed veterinarian, or to the extent permitted under <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=8-601" title="">Health Occupations Article, §8-601, Annotated Code of Maryland</a>, certified nurse midwife;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.12.01#B(1)(b)">(b)</span> A certified nurse practitioner to the extent permitted under <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=8-508" title="">Health Occupations Article, §8-508, Annotated Code of Maryland</a>; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.12.01#B(1)(c)">(c)</span> Another individual authorized by law to prescribe prescription or nonprescription drugs or devices.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.12.01#B(2)">(2)</span> "Board" means a health occupation licensing board:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.12.01#B(2)(a)">(a)</span> Authorized to issue a permit, license, or certificate under <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Annotated Code of Maryland</a>; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.12.01#B(2)(b)">(b)</span> That has regulatory authority over the permit holder or authorized prescriber who is responsible for the drugs or prescription records subject to impoundment.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.12.01#B(3)">(3)</span> "Department" means the Maryland Department of Health, or its authorized agent.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.12.01#B(4)">(4)</span> "Drug" means a prescription drug or device or a nonprescription drug, as defined in Health-General Article, §21-1113(a), Annotated Code of Maryland.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.12.01#B(5)">(5)</span> "Impoundment order" means an order issued by the Department to impound drugs or prescription records in accordance with Health-General Article, §21-1113, Annotated Code of Maryland, and this chapter.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.12.01#B(6)">(6)</span> "Permit holder" means a holder of, or applicant for:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.12.01#B(6)(a)">(a)</span> A pharmacy permit, manufacturer's permit, or distributor's permit issued by the State Board of Pharmacy under <a class="internal-link " href="https://mgaleg.maryland.gov/2023RS/Statute_Web/gho/gho.pdf" title="">Health Occupations Article, Title 12, Annotated Code of Maryland</a>; or</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.12.01#B(6)(b)">(b)</span> A dispensing permit issued by the board under the authority of <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gho&amp;section=12-102" title="">Health Occupations Article, §12-102(c)(2), Annotated Code of Maryland</a>.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.12.01#B(7)">(7)</span> "Prescription records" means records maintained by a permit holder or authorized prescriber which identify a patient and any medical information relating to that patient.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.12.01#B(8)">(8)</span> "Transfer" means the release of impounded drugs or prescription records by the department to a transferee.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.12.01#B(9)">(9)</span> "Transferee" means a permit holder or authorized prescriber to whom impounded drugs or prescription records are transferred in accordance with this chapter.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.13.12.02" data-order="|10|13|12|.02|" data-ref-path="10|13|12|.02" class="h__section">.02 Requirements for an Impoundment Order.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.12.02#A">A.</span> The Department may issue an impoundment order if:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.12.02#A(1)">(1)</span> A permit holder's permit or authorized prescriber's license has expired or has been revoked or suspended;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.12.02#A(2)">(2)</span> An application for a permit or license has been denied;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.12.02#A(3)">(3)</span> A board has:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.12.02#A(3)(a)">(a)</span> Determined that the permit holder or authorized prescriber failed to comply with a board order, letter of surrender, or law regarding the disposition of drugs or prescription records; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.12.02#A(3)(b)">(b)</span> Requested that the Department impound the drugs or prescription records;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.12.02#A(4)">(4)</span> The drugs pose an imminent threat to the public health, safety, or welfare; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.12.02#A(5)">(5)</span> The confidentiality of the prescription records is in imminent danger of being compromised.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.12.02#B">B.</span> The Department may issue an impoundment order based on:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.12.02#B(1)">(1)</span> On-site observation by a law enforcement official, the Department, or other regulatory official of drugs that pose imminent danger to the public health, safety, or welfare;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.12.02#B(2)">(2)</span> On-site observation by a law enforcement official, the Department, or other regulatory official that the confidentiality of prescription records is in imminent danger of being compromised;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.12.02#B(3)">(3)</span> Investigation by the Department or law enforcement authority sufficient to prove that drugs are posing an imminent danger to the public health, safety, or welfare, or that the confidentiality of prescription records is in imminent danger of being compromised; or</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.12.02#B(4)">(4)</span> Review of the board's licensing records that indicate the permit holder or authorized prescriber does not have the licensing or permit authority to possess drugs or prescription records.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.12.02#C">C.</span> Before execution of an impoundment order issued in accordance with Health-General Article, §21-1113(c)(1), Annotated Code of Maryland, the Department shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.12.02#C(1)">(1)</span> Attempt to serve written notice of the impoundment on the permit holder or authorized prescriber by certified mail at the last known address in the board's licensing files; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.12.02#C(2)">(2)</span> Provide the permit holder or authorized prescriber with an opportunity to:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.12.02#C(2)(a)">(a)</span> Avoid impoundment by allowing the permit holder or authorized prescriber to dispose of the drugs or prescription records in a manner acceptable to the Department;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.12.02#C(2)(b)">(b)</span> Review the nature, type, and amount of information upon which the Department issued the impoundment order; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.12.02#C(2)(c)">(c)</span> Avoid impoundment by providing the Department with information upon which the Department could reasonably conclude that the impoundment is not warranted.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.12.02#D">D.</span> Notice of Order of Impoundment.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.12.02#D(1)">(1)</span> If the Department issues an impoundment order in accordance with Health-General Article, §21-1113(c)(2), Annotated Code of Maryland, the Department shall attempt to contact the permit holder or authorized prescriber at the last known address or telephone number contained in the board's licensing files before executing the impoundment order.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.12.02#D(2)">(2)</span> Posting.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.12.02#D(2)(a)">(a)</span> If the Department is unsuccessful in contacting the permit holder or authorized prescriber before the execution of the impoundment order, the Department shall post the impoundment order in a conspicuous place at the site of the drugs or prescription records.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.12.02#D(2)(b)">(b)</span> The posted impoundment order shall contain information regarding:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.13.12.02#D(2)(b)(i)">(i)</span> The location of the impounded drugs or prescription records; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.13.12.02#D(2)(b)(ii)">(ii)</span> An individual to contact for further information.</p>
                <hr class="section-separator" aria-hidden="true"/>
                <h3 id="/us/md/exec/comar/10.13.12.03" data-order="|10|13|12|.03|" data-ref-path="10|13|12|.03" class="h__section">.03 Disposition of Impounded Drugs or Prescription Records.</h3>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.12.03#A">A.</span> If the Department executes an impoundment order against a permit holder or authorized prescriber, the Department shall:</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.12.03#A(1)">(1)</span> Arrange for the drugs or prescription records to be kept in a secure location;</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.12.03#A(2)">(2)</span> Ensure that any location which stores impounded drugs provides the necessary temperature controls and equipment to properly maintain the drugs; and</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.12.03#A(3)">(3)</span> Provide the permit holder or authorized prescriber with a list of all drugs and prescription records impounded.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.12.03#B">B.</span> Reclamation or Transfer.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.12.03#B(1)">(1)</span> The permit holder or authorized prescriber may petition the Department to reclaim or transfer the impounded drugs or prescription records within 30 days of the date of the impoundment order.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.12.03#B(2)">(2)</span> In order to reclaim or receive a transfer of impounded drugs or prescription records, the permit holder, authorized prescriber, or transferee shall demonstrate:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.12.03#B(2)(a)">(a)</span> Capability to maintain the impounded drugs or prescription records in compliance with all relevant State and federal laws;</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.12.03#B(2)(b)">(b)</span> Applicable licensing or permit authority to obtain possession of the impounded drugs or prescription records; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.12.03#B(2)(c)">(c)</span> If the impounded drugs or prescription records are to be transferred to a transferee, the existence of an express written agreement between the permit holder or authorized prescriber and the transferee, permitting the Department to release the impounded drugs or prescription records to the transferee.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.12.03#B(3)">(3)</span> If the Department grants a petition to reclaim or transfer impounded drugs or prescription records, the petitioner shall arrange for the removal and transport of the impounded drugs or prescription records.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.12.03#B(4)">(4)</span> Notice of Denial.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.12.03#B(4)(a)">(a)</span> If the Department denies a petition to reclaim or transfer impounded drugs or prescription records, the Department may destroy or transfer the impounded drugs or prescription records in accordance with <a class="internal-link " href="/us/md/exec/comar/10.13.12.03#C(2)" title="">§C(2) of this regulation</a> at least 15 days after the Department has attempted to serve notice by certified mail at the last known address of the permit holder or authorized prescriber.</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.12.03#B(4)(b)">(b)</span> The notice shall indicate that the Department:</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.13.12.03#B(4)(b)(i)">(i)</span> Has denied the petition; and</p>
                <p class="text-indent-4 "><span class="level-num" id="/us/md/exec/comar/10.13.12.03#B(4)(b)(ii)">(ii)</span> Intends to destroy or transfer the impounded drugs or prescription records.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.12.03#C">C.</span> Disposition of Drugs or Prescription Records if No Petition is Filed.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.12.03#C(1)">(1)</span> If the permit holder or authorized prescriber has not petitioned the Department within 30 days as provided in <a class="internal-link " href="/us/md/exec/comar/10.13.12.03#B" title="">§B of this regulation</a>, the Department may destroy or transfer the impounded drugs or prescription records.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.12.03#C(2)">(2)</span> The Department shall destroy or transfer:</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.12.03#C(2)(a)">(a)</span> Impounded drugs in accordance with all relevant State and federal laws, including Health-General Article, §21-1113(i), Annotated Code of Maryland; and</p>
                <p class="text-indent-3 "><span class="level-num" id="/us/md/exec/comar/10.13.12.03#C(2)(b)">(b)</span> Prescription records in accordance with Health-General Article, §§4-403 and 21-1113(i), Annotated Code of Maryland.</p>
                <p class="text-indent-1 "><span class="level-num" id="/us/md/exec/comar/10.13.12.03#D">D.</span> Reimbursement.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.12.03#D(1)">(1)</span> The permit holder or authorized prescriber shall reimburse the Department for the reasonable expenses relating to the collection, storage, and disposition of impounded drugs or prescription records.</p>
                <p class="text-indent-2 "><span class="level-num" id="/us/md/exec/comar/10.13.12.03#D(2)">(2)</span> The Department may require that the permit holder or authorized prescriber provide advance reimbursement to the Department as a precondition to granting a petition to reclaim or transfer impounded drugs or prescription records.</p>
                <hr class="section-separator" aria-hidden="true"/>
              </div>
            </article>
          </main>
          <nav id="area__navigation_mini" class="ns__document__maryland-dsd" aria-label="Previous and next article links">
            <section>
              <a href="/us/md/exec/comar/10.12" aria-label="Subtitle 12 ADULT HEALTH">
                <div class="h__ui">Previous</div>
                <span>Subtitle 12 ADULT HEALTH</span>
              </a>
            </section>
            <section>
              <a href="/us/md/exec/comar/10.14" aria-label="Subtitle 14 CANCER CONTROL">
                <div class="h__ui">Next</div>
                <span>Subtitle 14 CANCER CONTROL</span>
              </a>
            </section>
          </nav>
        </div>
      </div>
      <footer id="section__footer" class="ns__document__maryland-dsd">
        <div id="section__footer__inner" class="ns__document__maryland-dsd">
          <div id="area__footer__content" class="ns__document__maryland-dsd">
            <p>The codes and laws on this page are released under a CC-BY-SA license. 180 days after publication they will be dedicated to the public domain under the CC0 license.</p>
            <p>
      Please do not scrape. Instead, bulk download the CC-BY-SA <a href="https://github.com/maryland-dsd/law-html">HTML</a> or <a href="https://github.com/maryland-dsd/law-xml">XML</a> or CC0 <a href="https://github.com/maryland-dsd/law-html-cc0">HTML</a> or <a href="https://github.com/maryland-dsd/law-xml-cc0">XML</a>.
    </p>
            <p>Powered by the non-profit <a href="https://www.openlawlib.org/">Open Law Library</a>.</p>
          </div>
        </div>
      </footer>
    </div>
    <!--Piwik analytics-->
    <noscript>
      <img src="/_analytics/pixel.png" style="border:0;" alt=""/>
    </noscript>
  </body>
</html>
